Zoetis moves to acquire VitalRADS and expand teleradiology
Bottom line
Zoetis said on July 14, 2026, that it has agreed to acquire VitalRADS, a veterinary teleradiology services platform, expanding a relationship the companies began in August 2025. Zoetis said the deal will add 24/7 access to board-certified veterinary specialists through a cloud-based platform and deepen the imaging and consultation capabilities available through its diagnostics ecosystem. Financial terms were not disclosed. VitalRADS, founded in 2010 by veterinary radiologist Brian Poteet, has built its business around remote interpretation of radiographs, ultrasound, CT, MRI, echocardiography, and other imaging studies. (news.zoetis.com)
Why it matters: For veterinary professionals, this is another sign that large animal health companies are pushing to make diagnostics faster, more integrated, and more dependent on connected specialist networks. Zoetis has been positioning diagnostics as a strategic growth area, tying together in-clinic tools, cloud workflows, AI-supported image analysis, and specialist review. Bringing VitalRADS in-house could make it easier for practices already using ZoetisDx to access radiology consults within the same workflow, but it also underscores how quickly consolidation is reshaping referral support, turnaround expectations, and the competitive landscape in veterinary diagnostics. (zoetisdiagnostics.com)
What to watch: Watch for closing timing, any integration details for ZoetisDx users, and whether Zoetis expands VitalRADS services beyond teleradiology into broader specialist teleconsultation. (news.zoetis.com)
Zoetis is moving deeper into veterinary imaging with an agreement to acquire VitalRADS, a teleradiology platform that provides around-the-clock access to board-certified specialists. The company announced the deal on July 14, 2026, framing it as a way to accelerate diagnostic capabilities and build on the partnership it launched with VitalRADS in August 2025. Financial terms were not disclosed. (news.zoetis.com)
The acquisition fits a broader diagnostics strategy that Zoetis has been building for years. The company has steadily expanded beyond therapeutics into diagnostics, including prior investments in in-clinic testing, digital pathology, imaging workflows, genetics, and AI-enabled tools. In its recent corporate materials, Zoetis has highlighted diagnostics and precision animal health as growth priorities, and in a July 10, 2026, company blog post it emphasized using AI, cloud connectivity, and specialist support to deliver results faster for veterinary teams and pet parents. (sec.gov)
VitalRADS gives Zoetis a specialist services layer to pair with that infrastructure. According to Zoetis, the transaction adds 24/7 access to board-certified veterinary specialists through a cloud-based teleradiology platform. VitalRADS says it was founded in 2010 by Brian Poteet, MS, DVM, DACVR, DABSNM, later joined by Robert Werner, DVM, DACVR, and has built a team with deep experience in imaging, telemedicine, PACS, DICOM, and hospital information systems. On its site, VitalRADS says it interprets digital radiographs, abdominal and echocardiograms, ECGs, CT, MRI, and nuclear medicine studies, and also offers cardiology consultation. (news.zoetis.com)
This deal did not come out of nowhere. In August 2025, Zoetis integrated VitalRADS teleradiology into its Virtual Laboratory, giving ZoetisDx users access to specialist image interpretation through the existing portal. Zoetis’ diagnostics materials described that partnership as a way to streamline image submission and report retrieval inside the same workflow. The acquisition appears to formalize that arrangement and bring a previously partnered service directly under Zoetis control. (zoetisdiagnostics.com)
Public reaction so far has been limited, but the industry framing is clear: Zoetis is treating imaging data and specialist interpretation as strategic assets. Semafor reported that VitalRADS is Zoetis’ second data-focused acquisition of 2026 and tied the move to the company’s effort to build out diagnostics using AI. That interpretation aligns with Zoetis’ own messaging around combining cloud workflows, specialist review, and AI-assisted diagnostics. I’m inferring from those signals that Zoetis sees teleradiology not just as a service add-on, but as a way to strengthen the data, workflow, and clinical decision-support layers around its diagnostics business. (semafor.com)
Why it matters: For veterinary professionals, the practical value is convenience and speed. If a clinic is already working inside the Zoetis ecosystem, tighter integration could reduce friction in getting specialist reads, especially after hours or in markets with limited access to boarded radiologists. It may also raise expectations from pet parents for faster answers on imaging-heavy cases. At the same time, the acquisition adds to ongoing consolidation in veterinary diagnostics, where major companies are trying to own more of the workflow from test generation to interpretation. That can improve efficiency, but it can also narrow the field of independent service options over time. (zoetisdiagnostics.com)
The bigger strategic question is how far Zoetis takes the platform. VitalRADS already spans more than basic radiograph review, with services in advanced imaging and cardiology, and Zoetis has been explicit about building connected, data-rich diagnostic systems. If the company integrates VitalRADS more deeply into ZoetisDx and adjacent AI tools, practices could see a more unified imaging workflow, not just a bolt-on consult service. (vitalrads.com)
What to watch: The next milestones are the transaction close, any disclosures about integration timing, and whether Zoetis expands the VitalRADS model into broader teleconsultation or new AI-supported imaging products. It will also be worth watching whether competitors respond with their own specialist-network or workflow moves as the diagnostics arms race continues. (news.zoetis.com)